Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2/seipin-deficient mice

Weiqin Chen, Hongyi Zhou, Pradip Saha, Luge Li, Lawrence Chan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Bscl2-/- mice recapitulate many of the major metabolic manifestations in Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2) individuals, including lipodystrophy, hepatomegly, hepatic steatosis, and insulin resistance. The mechanisms that underlie hepatic steatosis and insulin resistance in Bscl2-/- mice are poorly understood. To address this issue, we performed hyperinsuline-mic-euglycemic clamp on Bscl2-/- and wild-type mice after an overnight (16-h) fast, and found that Bscl2-/- actually displayed increased hepatic insulin sensitivity. Interestingly, liver in Bscl2-/- mice after a short term (4-h) fast had impaired acute insulin signaling, a defect that disappeared after a 16-hour fast. Notably, fasting-dependent hepatic insulin signaling in Bscl2-/- mice was not associated with liver diacylglyceride and ceramide contents, but could be attributable in part to the expression of hepatic insulin signaling receptor and substrates. Meanwhile, increased de novo lipogenesis and decreased β-oxidation led to severe hepatic steatosis in fed or short-fasted Bscl2-/- mice whereas liver lipid accumulation and metabolism in Bscl2-/- mice was markedly affected by prolonged fasting. Furthermore, mice with liver-specific inactivation of Bscl2 manifested no hepatic steatosis even under high-fat diet, suggesting Bscl2 does not play a cell autonomous role in regulating liver lipid homeostasis. Overall, our results offered new insights into the metabolic adaptations of liver in response to fasting and uncovered a novel fasting-dependent regulation of hepatic insulin signaling in a mouse model of human BSCL2.

Original languageEnglish (US)
Pages (from-to)4215-4225
Number of pages11
JournalEndocrinology
Volume155
Issue number11
DOIs
StatePublished - Jan 1 2014

Fingerprint

Insulin Resistance
Fasting
Liver
Congenital Generalized Lipodystrophy
Insulin
Lipodystrophy
Lipogenesis
Glucose Clamp Technique
Ceramides
Insulin Receptor
High Fat Diet
Lipid Metabolism
Homeostasis
Lipids

ASJC Scopus subject areas

  • Endocrinology

Cite this

Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2/seipin-deficient mice. / Chen, Weiqin; Zhou, Hongyi; Saha, Pradip; Li, Luge; Chan, Lawrence.

In: Endocrinology, Vol. 155, No. 11, 01.01.2014, p. 4215-4225.

Research output: Contribution to journalArticle

@article{c6391e976f324962ab4760dce93ebe92,
title = "Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2/seipin-deficient mice",
abstract = "Bscl2-/- mice recapitulate many of the major metabolic manifestations in Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2) individuals, including lipodystrophy, hepatomegly, hepatic steatosis, and insulin resistance. The mechanisms that underlie hepatic steatosis and insulin resistance in Bscl2-/- mice are poorly understood. To address this issue, we performed hyperinsuline-mic-euglycemic clamp on Bscl2-/- and wild-type mice after an overnight (16-h) fast, and found that Bscl2-/- actually displayed increased hepatic insulin sensitivity. Interestingly, liver in Bscl2-/- mice after a short term (4-h) fast had impaired acute insulin signaling, a defect that disappeared after a 16-hour fast. Notably, fasting-dependent hepatic insulin signaling in Bscl2-/- mice was not associated with liver diacylglyceride and ceramide contents, but could be attributable in part to the expression of hepatic insulin signaling receptor and substrates. Meanwhile, increased de novo lipogenesis and decreased β-oxidation led to severe hepatic steatosis in fed or short-fasted Bscl2-/- mice whereas liver lipid accumulation and metabolism in Bscl2-/- mice was markedly affected by prolonged fasting. Furthermore, mice with liver-specific inactivation of Bscl2 manifested no hepatic steatosis even under high-fat diet, suggesting Bscl2 does not play a cell autonomous role in regulating liver lipid homeostasis. Overall, our results offered new insights into the metabolic adaptations of liver in response to fasting and uncovered a novel fasting-dependent regulation of hepatic insulin signaling in a mouse model of human BSCL2.",
author = "Weiqin Chen and Hongyi Zhou and Pradip Saha and Luge Li and Lawrence Chan",
year = "2014",
month = "1",
day = "1",
doi = "10.1210/en.2014-1292",
language = "English (US)",
volume = "155",
pages = "4215--4225",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2/seipin-deficient mice

AU - Chen, Weiqin

AU - Zhou, Hongyi

AU - Saha, Pradip

AU - Li, Luge

AU - Chan, Lawrence

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Bscl2-/- mice recapitulate many of the major metabolic manifestations in Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2) individuals, including lipodystrophy, hepatomegly, hepatic steatosis, and insulin resistance. The mechanisms that underlie hepatic steatosis and insulin resistance in Bscl2-/- mice are poorly understood. To address this issue, we performed hyperinsuline-mic-euglycemic clamp on Bscl2-/- and wild-type mice after an overnight (16-h) fast, and found that Bscl2-/- actually displayed increased hepatic insulin sensitivity. Interestingly, liver in Bscl2-/- mice after a short term (4-h) fast had impaired acute insulin signaling, a defect that disappeared after a 16-hour fast. Notably, fasting-dependent hepatic insulin signaling in Bscl2-/- mice was not associated with liver diacylglyceride and ceramide contents, but could be attributable in part to the expression of hepatic insulin signaling receptor and substrates. Meanwhile, increased de novo lipogenesis and decreased β-oxidation led to severe hepatic steatosis in fed or short-fasted Bscl2-/- mice whereas liver lipid accumulation and metabolism in Bscl2-/- mice was markedly affected by prolonged fasting. Furthermore, mice with liver-specific inactivation of Bscl2 manifested no hepatic steatosis even under high-fat diet, suggesting Bscl2 does not play a cell autonomous role in regulating liver lipid homeostasis. Overall, our results offered new insights into the metabolic adaptations of liver in response to fasting and uncovered a novel fasting-dependent regulation of hepatic insulin signaling in a mouse model of human BSCL2.

AB - Bscl2-/- mice recapitulate many of the major metabolic manifestations in Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2) individuals, including lipodystrophy, hepatomegly, hepatic steatosis, and insulin resistance. The mechanisms that underlie hepatic steatosis and insulin resistance in Bscl2-/- mice are poorly understood. To address this issue, we performed hyperinsuline-mic-euglycemic clamp on Bscl2-/- and wild-type mice after an overnight (16-h) fast, and found that Bscl2-/- actually displayed increased hepatic insulin sensitivity. Interestingly, liver in Bscl2-/- mice after a short term (4-h) fast had impaired acute insulin signaling, a defect that disappeared after a 16-hour fast. Notably, fasting-dependent hepatic insulin signaling in Bscl2-/- mice was not associated with liver diacylglyceride and ceramide contents, but could be attributable in part to the expression of hepatic insulin signaling receptor and substrates. Meanwhile, increased de novo lipogenesis and decreased β-oxidation led to severe hepatic steatosis in fed or short-fasted Bscl2-/- mice whereas liver lipid accumulation and metabolism in Bscl2-/- mice was markedly affected by prolonged fasting. Furthermore, mice with liver-specific inactivation of Bscl2 manifested no hepatic steatosis even under high-fat diet, suggesting Bscl2 does not play a cell autonomous role in regulating liver lipid homeostasis. Overall, our results offered new insights into the metabolic adaptations of liver in response to fasting and uncovered a novel fasting-dependent regulation of hepatic insulin signaling in a mouse model of human BSCL2.

UR - http://www.scopus.com/inward/record.url?scp=84908052440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908052440&partnerID=8YFLogxK

U2 - 10.1210/en.2014-1292

DO - 10.1210/en.2014-1292

M3 - Article

VL - 155

SP - 4215

EP - 4225

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 11

ER -